πŸ‡ΊπŸ‡Έ FDA
Patent

US 6069130

Ketoheterocyclic inhibitors of factor Xa

expired A61KA61K38/00A61P

Quick answer

US patent 6069130 (Ketoheterocyclic inhibitors of factor Xa) held by COR Therapeutics, Inc. expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K38/00, A61P, A61P7/02, A61P9/00